Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-09

FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approves a supplemental application for lisinopril filed by Quallent Pharmaceuticals Health LLC under ANDA 077321, enabling continued marketing of the gener…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)

Snippet

SUPPL AP for LISINOPRIL (LISINOPRIL)